Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Dermatologic 1

Conditions

Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Cyclophosphamide 910Carboplatin 787pembrolizumab 746Paclitaxel 743Cisplatin 709Bevacizumab 707Gemcitabine 619Docetaxel 580Rituximab 549Radiotherapy 541Dexamethasone 512Nivolumab 489Doxorubicin 445Fluorouracil 392Capecitabine 376Etoposide 358Pemetrexed 337Cytarabine 335Oxaliplatin 333Lenalidomide 328Prednisone 327fludarabine phosphate 316Erlotinib Hydrochloride 314Trastuzumab 300Leucovorin 299fludarabine 296Vincristine 287Filgrastim 284Bortezomib 284Cetuximab 276

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Has results × remetinostat × Clear all
NCT03180528 2021-06-08

Topical Remetinostat in Treating Patient With Cutaneous Basal Cell Cancer

Stanford University

Phase 2 Completed
30 enrolled 10 charts
Dermatologic

Carcinoma, Basal Cell

NCT03875859 2021-05-20

Topical Remetinostat Gel as Neoadjuvant Therapy in Patients With Squamous Cell Carcinoma (SCC)

Stanford University

Phase 2 Terminated
4 enrolled 9 charts
Tumor-Agnostic

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡